{
  "generated": "2025-11-06T07:16:49.714401+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/metabolic/pterostilbene-long-gen-0644/longevity/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "LONG-GEN-0644_01",
      "year": 2018,
      "design": "randomized controlled trial",
      "journal": "longevity_journal",
      "outcome": "senescence",
      "population": "Adults with senescence concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/pterostilbene-long-gen-0644-01",
      "url": "https://doi.org/10.1234/pterostilbene-long-gen-0644-01",
      "citation": "LONG-GEN-0644_01 (2018); Journal: longevity_journal; Design: randomized controlled trial; Population: Adults with senescence concerns; Outcome: senescence; DOI: 10.1234/pterostilbene-long-gen-0644-01; Adverse Events: None reported."
    },
    {
      "study_id": "LONG-GEN-0644_02",
      "year": 2019,
      "design": "randomized controlled trial",
      "journal": "longevity_journal",
      "outcome": "senescence",
      "population": "Adults with senescence concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/pterostilbene-long-gen-0644-02",
      "url": "https://doi.org/10.1234/pterostilbene-long-gen-0644-02",
      "citation": "LONG-GEN-0644_02 (2019); Journal: longevity_journal; Design: randomized controlled trial; Population: Adults with senescence concerns; Outcome: senescence; DOI: 10.1234/pterostilbene-long-gen-0644-02; Adverse Events: None reported."
    },
    {
      "study_id": "LONG-GEN-0644_03",
      "year": 2020,
      "design": "randomized controlled trial",
      "journal": "longevity_journal",
      "outcome": "senescence",
      "population": "Adults with senescence concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/pterostilbene-long-gen-0644-03",
      "url": "https://doi.org/10.1234/pterostilbene-long-gen-0644-03",
      "citation": "LONG-GEN-0644_03 (2020); Journal: longevity_journal; Design: randomized controlled trial; Population: Adults with senescence concerns; Outcome: senescence; DOI: 10.1234/pterostilbene-long-gen-0644-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/pterostilbene-long-gen-0644-01",
      "study_ids": [
        "LONG-GEN-0644_01"
      ],
      "primary_study_id": "LONG-GEN-0644_01",
      "url": "https://doi.org/10.1234/pterostilbene-long-gen-0644-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/pterostilbene-long-gen-0644-02",
      "study_ids": [
        "LONG-GEN-0644_02"
      ],
      "primary_study_id": "LONG-GEN-0644_02",
      "url": "https://doi.org/10.1234/pterostilbene-long-gen-0644-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/pterostilbene-long-gen-0644-03",
      "study_ids": [
        "LONG-GEN-0644_03"
      ],
      "primary_study_id": "LONG-GEN-0644_03",
      "url": "https://doi.org/10.1234/pterostilbene-long-gen-0644-03"
    }
  ],
  "manifest_hash": "sha256:749ce7061107a75e6ef3ed524e72efbaf0eb7be794706a0ddeba24e5682de63a"
}
